Use your antibodies-online credentials, if available.
TFPI encodes a protease inhibitor that regulates the tissue factor (TF)-dependent pathway of blood coagulation. 再加上，我们可以发TFPI 抗体 (184) 和 TFPI 蛋白 (32)和数多这个蛋白质的别的产品。
Showing 10 out of 92 products:
Mouse (Murine) TFPI ELISA Kit for Sandwich ELISA - ABIN415387
Walter, Steinwede, Aly, Reinheckel, Bohling, Maus, Ehlers: Cathepsin G in Experimental Tuberculosis: Relevance for Antibacterial Protection and Potential for Immunotherapy. in Journal of immunology (Baltimore, Md. : 1950) 2015
Show all 3 Pubmed References
Human TFPI ELISA Kit for Sandwich ELISA - ABIN1672813
Xu, Qin, Zhou, Tu, Bi, Li, Fan, Zhang: Tissue factor pathway inhibitor-2 inhibits the growth and invasion of hepatocellular carcinoma cells and is inactivated in human hepatocellular carcinoma. in Oncology letters 2012
Human TFPI ELISA Kit for Sandwich ELISA - ABIN416737
Farid, Mohammed, Afifi, Beltagi: Tissue factor pathway inhibitor in paediatric patients with nephrotic syndrome. in SAJCH : the South African journal of child health 2012
TFPI-1 interacts with AMOT (显示 AMOT ELISA试剂盒), which led to a decrease in the phosphorylation of YAP (显示 YAP1 ELISA试剂盒) and further increased the genes expression of the proliferation and migration involved. Our results further confirmed that atherosclerosis was a localized disease.
Results suggest that endothelial cell-anchored TFPI controls lung tumor metastasis, and does so largely through the inhibition of local TF-induced thrombin (显示 F2 ELISA试剂盒) generation and the regulation of the lung microenvironment in mice.
Data argue against an important role for endogenous TFPI in the antibacterial, inflammatory and procoagulant response during pneumococcal pneumonia.
TFPI has an anti-proliferative role in TNF-alpha (显示 TNF ELISA试剂盒) stimulated-VSMCs at least partly by interfering with the MCP-3 (显示 CCL7 ELISA试剂盒)/CCR2 (显示 CCR2 ELISA试剂盒) pathway and then via suppression of the ERK1/2 (显示 MAPK1/3 ELISA试剂盒) and PI3K/AKT (显示 AKT1 ELISA试剂盒) signaling pathways
Results demonstrate that TFPI physiologically modulates thrombin (显示 F2 ELISA试剂盒)-dependent platelet activation in a manner that is required for successful embryonic development
Tissue factor (显示 F3 ELISA试剂盒) plays a hitherto unreported role in the generation of macrophage migratory inhibitory factor by vascular smooth muscle cells in atherosclerosis-prone ApoE (显示 APOE ELISA试剂盒)(-/-) mice.
The increased plasmin (显示 PLG ELISA试剂盒) generation during the early stages of sepsis could cleave/inactivate TFPI and thus lead to thrombotic complications.
structural features within residues of the 39-loop contribute to the resistance of FIXa (显示 ETFB ELISA试剂盒) to inhibition by plasma inhibitors ZPI (显示 SERPINA10 ELISA试剂盒) and TFPI.
PAK1 (显示 PAK1 ELISA试剂盒) negatively regulates the expression of TFPI and additionally contributes to increased TF activity.
Murine models of combined TFPI and factor VIII deficiency were used to examine the impact of TFPI deficiency on bleeding and clotting in hemophilia
miR (显示 MLXIP ELISA试剂盒)-27a/b and miR (显示 MLXIP ELISA试剂盒)-494 regulate TFPIalpha expression; there may be a role of these miRNAs in the estrogen-mediated downregulation of TFPIalpha
Genetic variations of the TFPI genes seem to be related with coronary artery disease, which likely cooperate with metabolic risk factor (diabetes mellitus) and play critical roles in the pathogenesis of coronary artery disease in Han Chinese.
Cleavage of FV at Arg(1545) , which abolishes the anticoagulant properties of FV and commits FV to the procoagulant pathway, is inhibited by binding of the TFPIalpha C-terminus to the FV acidic region
The aim of this study was to evaluate the concentration of TF and its inhibitor TFPI in blood plasma, the impact of traditional and non-traditional cardiovascular risk factors on their concentration and the impact of both markers of haemostasis on the severity of subclinical atherosclerosis.
The results show that cholesterol crystals induce TFPI and cytokine expression in M2-polarized macrophages through activation of the endoplasmic reticulum stress pathway and that TFPI has a protective effect against TNF-alpha (显示 TNF ELISA试剂盒) and IL-6 (显示 IL6 ELISA试剂盒) mediated inflammation.
Among high-risk women, the tissue factor pathway inhibitor activity of patients with gestational vascular complications is higher than that in other patients. Hence, these markers could augment a screening strategy.
TFPI single nucleotide polymorphism is associated with venous thromboembolism.
a concentration of tissue factor pathway inhibitor was significantly lower in patients with essential thrombocythemia with JAK2 (显示 JAK2 ELISA试剂盒) V617F mutation as compared with patients without the mutation
This review presents a comprehensive understanding of TFPI structure, biochemistry, and cellular expression which is necessary to understand how it modulates bleeding in hemophilia and the physiological impact of therapeutic agents targeting TFPI.
the main finding of the current study is the remarkable elevation in the plasma levels of both total and free TFPI in septic patients at baseline. The levels of both forms of the inhibitor remained elevated throughout the first 24 h with further elevation after enoxaparin administration.
Upregulated TF expression and increased plasma TF level during reperfusion period, reduced plasma TFPI-1 level during reperfusion period.
This gene encodes a protease inhibitor that regulates the tissue factor (TF)-dependent pathway of blood coagulation. The coagulation process initiates with the formation of a factor VIIa-TF complex, which proteolytically activates additional proteases (factors IX and X) and ultimately leads to the formation of a fibrin clot. The product of this gene inhibits the activated factor X and VIIa-TF proteases in an autoregulatory loop. The encoded protein is glycosylated and predominantly found in the vascular endothelium and plasma in both free forms and complexed with plasma lipoproteins. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been confirmed.
extrinsic pathway inhibitor
, lipoprotein-associated coagulation inhibitor
, uncharacterized protein LOC100155068
, tissue factor pathway inhibitor